| |
| |
|
| Insider
Information: |
Santel Donald J |
| Relationship: |
Former Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
30,000 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$15,000 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
30,000 |
|
|
| Total
Value |
$15,000 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Hyperion Therapeutics Inc |
HPTX |
CEO & President, Direc... |
2015-05-07 |
0 |
2015-05-07 |
0 |
Premium* |
|
|
Oyster Point Pharma, Inc. |
OYST |
Director |
2023-01-03 |
0 |
2021-07-30 |
0 |
Premium* |
|
|
Surrozen Ord Shs |
SRZN |
Former Director |
2021-08-11 |
30,000 |
2021-08-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OYST |
Oyster Point Pharma, Inc. |
Director |
– • – |
2023-01-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(8,198) |
0 |
0 |
- |
|
| OYST |
Oyster Point Pharma, Inc. |
Director |
– • – |
2023-01-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,489) |
8,198 |
0 |
- |
|
| OYST |
Oyster Point Pharma, Inc. |
Director |
– • – |
2022-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,573 |
13,687 |
0 |
- |
|
| SRZN |
Surrozen Ord Shs |
Former Director |
– – – |
2021-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| OYST |
Oyster Point Pharma, Inc. |
Director |
– • – |
2021-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
10,114 |
10,114 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
CEO & President |
• • – |
2015-05-07 |
4 |
D |
$46.00 |
$15,912,872 |
D/D |
(345,932) |
0 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
CEO & President |
• • – |
2015-05-07 |
4 |
D |
$46.00 |
$467,544 |
I/I |
(10,164) |
0 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
CEO & President |
• • – |
2015-05-07 |
4 |
D |
$46.00 |
$106,076 |
D/D |
(2,306) |
0 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
CEO & President |
• • – |
2015-05-01 |
4 |
OE |
$1.28 |
$675,573 |
D/D |
292,057 |
348,535 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
CEO & President |
• • – |
2015-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
56,478 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
CEO & President |
• • – |
2015-01-02 |
4 |
D |
$24.28 |
$49,094 |
D/D |
(2,022) |
16,478 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
CEO & President |
• • – |
2014-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
18,500 |
18,500 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
CEO & PresidentOfficer |
• • – |
2012-07-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
10,164 |
|
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
